Trial intelligence / Profile preview

Novaferon and Capecitabine in Metastatic Colorectal Cancer

NCT02068131Phase 2Unknown

Sponsor
307 Hospital of the People's Liberation Army
Start
Feb 2014
Primary completion
Nov 2016
Modality
Cytokines & Interferons
Countries
1
01

Overview

A Phase 2 trial of novaferon in colorectal cancer (metastatic) (mCRC), sponsored by 307 Hospital of the People's Liberation Army. Status: unknown.

02

Drugs

novaferon
03

Conditions

colorectal cancer (metastatic) (mCRC)

Beyond the preview

Go deeper on NCT02068131.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02068131.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call